58-55-9

  • Product Name:Theophylline Anhydrous
  • Molecular Formula:C7H8N4O2
  • Purity:99%
  • Molecular Weight:180.166
Inquiry

Product Details:

CasNo: 58-55-9

Molecular Formula: C7H8N4O2

Appearance: white to light yellow crystal powder

Factory Supply High Purity Theophylline Anhydrous 58-55-9 Low Price

  • Molecular Formula:C7H8N4O2
  • Molecular Weight:180.166
  • Appearance/Colour:white to light yellow crystal powder 
  • Vapor Pressure:2.72E-06mmHg at 25°C 
  • Melting Point:271-273 °C 
  • Refractive Index:1.737 
  • Boiling Point:454.091 °C at 760 mmHg 
  • PKA:8.77(at 25℃) 
  • Flash Point:228.426 °C 
  • PSA:72.68000 
  • Density:1.466 g/cm3 
  • LogP:-1.03970 

Theophylline Anhydrous (Cas 58-55-9) Usage

Chemical Structure and Derivatives

Theophylline is a methylxanthine alkaloid and a xanthine derivative.
There are more than 300 derivatives of theophylline, including aminophylline, dihydroxypropyl theophylline, oxtriphylline, and others.

Description

Theophylline Anhydrous is a xanthine derivative medication used in the treatment of respiratory diseases, particularly for chronic therapy. It acts as a weak bronchodilator, helping to alleviate symptoms associated with various lung conditions.

Chemical Properties

white to light yellow crystal powder

Uses Theophylline Anhydrous is indicated for the management of asthma, a chronic inflammatory condition characterized by airway obstruction, inflammation, and bronchospasm. It is used to manage the reversible component of airway obstruction associated with chronic obstructive pulmonary disease (COPD).
Brand and Availability Uniphyl (Theophylline, Anhydrous) is a bronchodilator medication previously available under the brand name Uniphyl. 

InChI:InChI=1/C7H10N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3-5H,1-2H3,(H,8,9)

58-55-9 Relevant articles

Coordination polymers as potential solid forms of drugs: Three zinc(ii) coordination polymers of theophylline with biocompatible organic acids

Lou, Benyong,He, Fengdan

, p. 309 - 316 (2013)

The biocompatible organic acids such as ...

Sleep Quality and Nocturnal Respiratory Function With Once-Daily Theophylline (Uniphyl) and Inhaled Salbutamol in Patients With COPD

Godfrey C.W. Man MB, BS, FCCP a, Kenneth R. Chapman MD, FCCP b, S. Habib Ali PhD c, Andrew C. Darke PhD c

, Chest, Volume 110, Issue 3, September 1996, Pages 648-653

We conclude that, compared with salbutamol, evening administration of once-daily theophylline results in better nocturnal oxygen saturation and an improvement in the overnight change in pulmonary function, without affecting sleep architecture, in patients with COPD.

Inhibition of radical-induced DNA strand breaks by water-soluble constituents of coffee: Phenolics and caffeine metabolites

Rathod,Patel,Das,Tipparaju,Shinde,Anderson, Robert F.

, p. 480 - 487 (2013)

Epidemiological studies have associated ...

SERS multiplexing of methylxanthine drug isomersviahost-guest size matching and machine learning

Chio, Weng-I Katherine,Dinish, U. S.,Jones, Tabitha,Lee, Tung-Chun,Liu, Jia,Olivo, Malini,Parkin, Ivan P.,Perumal, Jayakumar

supporting information, p. 12624 - 12632 (2021/10/06)

Multiplexed detection and quantification...

Polymorphism in Anhydrous Theophylline—Implications on the Dissolution Rate of Theophylline Tablets

Neelima V. Phadnis, Raj Suryanarayanan

, Journal of Pharmaceutical Sciences Volume 86, Issue 11, November 1997, Pages 1256-1263

I* was prepared by dehydration of theophylline monohydrate (II). Variable temperature X-ray powder diffractometry of II revealed the following series of transitions: II → I* → I. The metastable anhydrate, I*, which has not yet been reported in the literature, appears to be related monotropically to I.

58-55-9 Process route

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2,138455-22-8,95789-13-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

theophylline
58-55-9,75448-53-2

theophylline

theobromine /
83-67-0

theobromine /

paraxanthine
611-59-6

paraxanthine

1,3,7-trimethyluric acid
5415-44-1

1,3,7-trimethyluric acid

Conditions
Conditions Yield
With phosphate buffer; NADPH; recombinant rat cytochrome P450 1A2; at 37 ℃; Further Variations:; Catalysts; Enzyme kinetics;
 
With NADPH; human cDNA-expressed cytochrome P450 1A2 (supersomes); In phosphate buffer; at 37 ℃; for 60h; pH=7.4; Further Variations:; Reagents; Enzyme kinetics;
 
3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
58-08-2,138455-22-8,95789-13-2

3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione

theophylline
58-55-9,75448-53-2

theophylline

theobromine /
83-67-0

theobromine /

paraxanthine
611-59-6

paraxanthine

Conditions
Conditions Yield
With hepatic cytochrome P450; Enzymatic reaction;
12%
7%

58-55-9 Upstream products

  • 290-87-9
    290-87-9

    1,3,5-Triazine

  • 5440-00-6
    5440-00-6

    4,5-Diamino-1,3-dimethyluracil

  • 6642-31-5
    6642-31-5

    6-Amino-1,3-dimethylbarbituric acid

  • 77287-34-4
    77287-34-4

    formamide

58-55-9 Downstream products

  • 519-37-9
    519-37-9

    7-(2-hydroxyethyl)theophylline

  • 5089-89-4
    5089-89-4

    1,3-dimethyl-7-(morpholinomethyl)xanthine

  • 603-00-9
    603-00-9

    proxyphylline

  • 19264-77-8
    19264-77-8

    7-[(2-hydroxy-2-phenyl)ethyl]theophylline

Relevant Products